Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RSS0343 in COPD
NCT07349524Phase 2Recruiting
- Sponsor
- Reistone Biopharma
- Start
- Mar 2026
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RSS0343 in chronic obstructive pulmonary disease (COPD), sponsored by Reistone Biopharma. Started Mar 2026; status: recruiting.
02
Drugs
RSS0343
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07349524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07349524.